Target Name: MIR6511B1
NCBI ID: G102465429
Review Report on MIR6511B1 Target / Biomarker Content of Review Report on MIR6511B1 Target / Biomarker
MIR6511B1
Other Name(s): microRNA 6511b-1 | hsa-mir-6511b-1 | MicroRNA 6511b-1 | hsa-miR-6511b-5p | MIR6511B-1 | hsa-miR-6511b-3p

MIR6511B1: A Non-Code RNA Molecule Regulating Cellular Processes

MicroRNA 6511b-1 (MIR6511B1) is a non-coding RNA molecule that plays a crucial role in regulating various cellular processes. It is a member of the 6511 gene family, which encodes small non-coding RNAs (ncRNAs) that are involved in various cellular processes. MIR6511B1 is one of the non-coding RNAs that belong to the 6511 gene family.

MIR6511B1 is a short RNA molecule that contains only 19 amino acid residues. It is characterized by its ability to interact with various cellular proteins, including activator protein 1 (AP-1), which is a transcription factor that plays a role in the regulation of cellular processes such as cell growth, differentiation, and apoptosis.

One of the unique features of MIR6511B1 is its ability to interact with AP-1 in a specific way. MIR6511B1 has a unique binding site on the AP-1 protein, which allows it to form a stable complex with the transcription factor. This interaction between MIR6511B1 and AP-1 has been shown to play a role in the regulation of various cellular processes, including cell growth, differentiation, and apoptosis.

Another interesting feature of MIR6511B1 is its ability to interact with the protein p21 (TNFAIP3). MIR6511B1 has a unique binding site on the p21 protein, which allows it to form a stable complex with the transcription factor. This interaction between MIR6511B1 and p21 has been shown to play a role in the regulation of cellular processes such as cell growth, apoptosis, and inflammation.

MIR6511B1 has also been shown to interact with the protein heat shock protein (Hsp70) HSP70A1. MIR6511B1 has a unique binding site on the HSP70A1 protein, which allows it to form a stable complex with the transcription factor. This interaction between MIR6511B1 and HSP70A1 has been shown to play a role in the regulation of cellular processes such as cell growth, apoptosis, and stress resistance.

In addition to its interactions with AP-1, p21, and HSP70A1, MIR6511B1 has also been shown to interact with several other proteins, including the protein casein (CAPN1/PAI-1). MIR6511B1 has a unique binding site on the CAPN1 protein, which allows it to form a stable complex with the transcription factor. This interaction between MIR6511B1 and CAPN1 has been shown to play a role in the regulation of cellular processes such as cell growth, apoptosis, and inflammation.

MIR6511B1 has also been shown to interact with the protein PyR (PRY30/PAZ). MIR6511B1 has a unique binding site on the PyR protein, which allows it to form a stable complex with the transcription factor. This interaction between MIR6511B1 and PyR has been shown to play a role in the regulation of cellular processes such as cell growth, apoptosis, and inflammation.

In conclusion, MIR6511B1 is a non-coding RNA molecule that plays a crucial role in regulating various cellular processes. Its unique ability to interact with various cellular proteins, including activator protein 1 (AP-1), p21, HSP70A1, casein (CAPN1/PAI-1), PyR, and Hsp70A1, has been shown to play a role in the regulation of cellular processes such as cell growth, apoptosis, and inflammation. Therefore, MIR6511B1 may be a potential drug target or biomarker for various diseases. Further research is needed to fully understand the role of MIR6511B1 in cellular processes and its potential as a drug or biomarker.

Protein Name: MicroRNA 6511b-1

The "MIR6511B1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR6511B1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR6511B2 | MIR6512 | MIR6513 | MIR6514 | MIR6515 | MIR6516 | MIR652 | MIR653 | MIR654 | MIR655 | MIR656 | MIR657 | MIR658 | MIR659 | MIR660 | MIR661 | MIR662 | MIR663A | MIR663AHG | MIR663B | MIR664A | MIR664B | MIR665 | MIR668 | MIR670 | MIR671 | MIR6715A | MIR6715B | MIR6716 | MIR6717 | MIR6718 | MIR6719 | MIR6720 | MIR6721 | MIR6722 | MIR6724-1 | MIR6726 | MIR6727 | MIR6728 | MIR6729 | MIR6730 | MIR6731 | MIR6732 | MIR6733 | MIR6734 | MIR6735 | MIR6736 | MIR6737 | MIR6738 | MIR6739 | MIR6740 | MIR6741 | MIR6742 | MIR6743 | MIR6744 | MIR6746 | MIR6747 | MIR6748 | MIR6749 | MIR675 | MIR6750 | MIR6751 | MIR6752 | MIR6753 | MIR6754 | MIR6755 | MIR6756 | MIR6757 | MIR6758 | MIR6759 | MIR676 | MIR6760 | MIR6761 | MIR6762 | MIR6763 | MIR6764 | MIR6765 | MIR6766 | MIR6767 | MIR6768 | MIR6769A | MIR6769B | MIR6770-1 | MIR6770-2 | MIR6770-3 | MIR6771 | MIR6772 | MIR6773 | MIR6774 | MIR6775 | MIR6776 | MIR6777 | MIR6778 | MIR6779 | MIR6780A | MIR6780B | MIR6781 | MIR6782 | MIR6783 | MIR6784